Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne zoonotic disease, endemic in Africa, with a high case fatality rate. There is no efficient treatment or licensed vaccine. This study aimed to determine the prevalence of CCHFV in cattle in extensive grazing systems (both pastoralism and ranching) within the Maasai Mara ecosystem, Nanyuki, and the Ol Pejeta Conservancy in Kenya. We conducted a seroepidemiological study of the sera of 148 cattle from 18 households from the three ecosystems in 2014, 2016, and 2019. Sera from 23 sheep and 17 goats were also obtained from the same households during the same period. Sera were analyzed for the presence of antibodies to CCHFV using the commercially available double-antigen ELISA kit. Overall, 31.5% CCHFV seropositivity was observed. The prevalence of CCHF was analyzed using a multiple logistic mixed model with main predictors. Risk factors associated with exposure to CCHFV were age (p = 0.000) and season (p = 0.007). Our findings suggest exposure to CCHFV and point to cattle as likely reservoirs of CCHFV in Kenya. The findings might play a role in providing better insights into disease risk and dynamics where analysis of tick populations in these regions should be further investigated.

Highlights

  • Crimean-Congo hemorrhagic fever virus (CCHFV) belongs to the order Bunyavirales, family Nairoviridae, genus Orthonairovirus [1]

  • CCHFV is the causative agent of Crimean-Congo hemorrhagic fever (CCHF) that has a case fatality ranging from 5 to 80% [3]

  • Humans are susceptible to the virus, with symptoms spanning from nonspecific febrile illness to severe hemorrhagic disease [5]

Read more

Summary

Introduction

Crimean-Congo hemorrhagic fever virus (CCHFV) belongs to the order Bunyavirales, family Nairoviridae, genus Orthonairovirus [1]. CCHFV has a wide distribution, occurring in western China, across southern Asia to the Middle East, and in Spain, the Balkans, and. CCHFV is the causative agent of Crimean-Congo hemorrhagic fever (CCHF) that has a case fatality ranging from 5 to 80% [3]. CCHF is classified as a priority disease requiring urgent research and development attention due to its high risk to public health and national security [4]. Humans are susceptible to the virus, with symptoms spanning from nonspecific febrile illness to severe hemorrhagic disease [5]. Information on the distribution and genetic diversity of CCHFV is quite limited [9]

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call